Business Context and Reporting Period
Company: Herbalife Ltd.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2026
Business Overview: Herbalife is a global nutrition company selling weight management, targeted nutrition, energy, sports, fitness, and outer nutrition products through a network of independent members. The company operates in five geographic regions: North America, Latin America, EMEA, Asia Pacific (excluding China), and China.
Key Financial Metrics
| Metric (in millions) | Three Months Ended June 30, 2026 |
Six Months Ended June 30, 2026 |
|---|---|---|
| Net Sales | $1,326.8 | $2,644.0 |
| Gross Profit | $1,030.5 | $2,056.6 |
| Operating Income | $128.3 | $266.7 |
| Net (Loss) Income Attributable to Herbalife | $(26.3) | $35.6 |
| Diluted EPS | $(0.25) | $0.33 |
| Operating Cash Flow | N/A | $146.7 |
| Cash and Cash Equivalents | $370.5 | $370.5 |
| Total Debt (Carrying Value) | $2,015.7 | $2,015.7 |
Margins (Six Months Ended June 30, 2026):
- Gross Margin: 77.8%
- Operating Margin: 10.1%
- Net Margin: 1.3%
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 5.4% ($67.7M) for the quarter and 6.6% ($163.2M) for the six months compared to the same periods in 2025. Growth was driven by sales volume increases and price hikes, partially offset by unfavorable sales mix and foreign currency fluctuations.
- Profitability Decline: Net income attributable to Herbalife decreased 153.3% for the quarter (turning from a $49.3M profit to a $26.3M loss) and 64.3% for the six months ($99.7M to $35.6M). The primary driver was a $94.6 million loss on extinguishment of debt related to refinancing activities in April 2026.
- Expense Increases: General and administrative expenses rose significantly due to higher labor/benefits costs and non-income tax expenses (primarily India GST). Selling expenses increased due to higher net sales volume.
- Interest Expense: Net interest expense decreased by $16.2M (quarter) and $21.4M (six months) due to the April 2026 debt refinancing which lowered the weighted-average interest rate.
- Geographic Performance:
- Asia Pacific: Strong growth (+15.2% QoQ), led by India (+32.9%) and Vietnam (+7.3%).
- Latin America: Solid growth (+16.6% QoQ), driven by Mexico (+17.3%).
- China: Significant decline (-24.5% QoQ) due to a 28.7% drop in sales volume.
- EMEA: Decline (-3.5% QoQ) driven by volume decreases in Italy and Germany.
Guidance, Outlook, and Risks
Debt Refinancing: In April 2026, the company refinanced its 2024 Credit Facility and fully redeemed $800M of 2029 Secured Notes. It issued $800M of new 7.750% Senior Secured Notes due 2033 and established a new 2026 Credit Facility ($225M Term Loan A + $425M Revolver). This resulted in the $94.6M loss on extinguishment but reduced future interest costs.
Acquisitions:
- Bioniq: Acquired core personalized nutrition assets for a base consideration of $55M (payable over 5 years) plus up to $95M in contingent payments. Recorded $26.8M in goodwill.
- Pro2col: Cristiano Ronaldo acquired a 10% minority interest in the Pro2col Software subsidiary for $7.5M.
Risks and Contingencies:
- Tax Matters: Significant ongoing tax assessments in Brazil (ICMS/ICMS-ST), Mexico (VAT), and India (GST/Income Tax). The company has not accrued losses for most as it believes a loss is not probable, but outcomes remain uncertain.
- Legal Proceedings: Ongoing class action lawsuit in California regarding distributor misclassification; litigation against a former technology vendor (verdict in favor of Herbalife, punitive damages trial pending).
- Macroeconomic Factors: Exposure to inflation, foreign exchange fluctuations, and geopolitical conflicts (Ukraine, Middle East) impacting supply chain and costs.
Restructuring: The company initiated an "Optimization Program" in Q2 2026 to improve global operating efficiency. Costs are currently estimated at $1.3M for the quarter, with future costs not yet estimable.
Investor Verification Checklist
- Debt Extinguishment Impact: Verify the non-recurring nature of the $94.6M loss and its effect on the effective tax rate and future interest expense projections.
- China Sales Volume: Investigate the drivers behind the 28.7% volume decline in China and the effectiveness of digital initiatives to reverse this trend.
- Tax Contingencies: Review the status of tax assessments in Brazil, Mexico, and India to assess potential future cash outflows or asset write-downs.
- Bioniq Integration: Monitor the integration of Bioniq assets and the likelihood of achieving the sales milestones required for the $95M contingent consideration.
- India GST Impact: Confirm the sustainability of the sales growth in India following the GST rate reduction and the impact of higher non-income tax expenses on margins.